The US FDA in its Enforcement Report said that Glenmark Pharma's US branch is recalling a specific lot of Diltiazem Hydrochloride extended-release capsules due to ‘failed dissolution specifications’ Read The Rest at :
Disclaimer : Mymoneytimes implements extreme caution and care in collecting data before publication. Mymoneytimes does not liable for the adequacy, accuracy or completeness of any given information. Hence we are not liable for any kind of direct or indirect loss caused by the use of such information.
